As of 2026-01-02, the Relative Valuation of Revive Therapeutics Ltd (RVV.CN) is (0.21) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 CAD, the upside of Revive Therapeutics Ltd based on Relative Valuation is -2190.4%.
The range of the Relative Valuation is (0.17) - (0.25) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 26.6x | 22.2x |
| Forward P/E multiples | 17.2x - 25.9x | 21.6x |
| Fair Price | (0.17) - (0.25) | (0.21) |
| Upside | -1797.2% - -2571.2% | -2190.4% |
| Date | P/E |
| 2025-12-31 | -1.05 |
| 2025-12-30 | -1.05 |
| 2025-12-29 | -1.05 |
| 2025-12-24 | -1.05 |
| 2025-12-23 | -1.05 |
| 2025-12-22 | -1.05 |
| 2025-12-19 | -1.05 |
| 2025-12-17 | -1.05 |
| 2025-12-16 | -1.57 |
| 2025-12-15 | -1.57 |
| 2025-12-12 | -1.57 |
| 2025-12-11 | -1.57 |
| 2025-12-10 | -1.57 |
| 2025-12-09 | -1.57 |
| 2025-12-08 | -1.05 |
| 2025-12-05 | -2.62 |
| 2025-12-04 | -1.57 |
| 2025-12-03 | -1.05 |
| 2025-12-02 | -1.05 |
| 2025-12-01 | -1.05 |
| 2025-11-28 | -1.05 |
| 2025-11-27 | -1.05 |
| 2025-11-26 | -1.57 |
| 2025-11-25 | -1.05 |
| 2025-11-24 | -1.05 |
| 2025-11-21 | -1.05 |
| 2025-11-20 | -1.05 |
| 2025-11-19 | -1.05 |
| 2025-11-18 | -1.05 |
| 2025-11-17 | -1.05 |
| 2025-11-14 | -1.05 |
| 2025-11-13 | -1.05 |
| 2025-11-11 | -1.05 |
| 2025-11-10 | -1.05 |
| 2025-11-07 | -1.05 |
| 2025-11-06 | -1.57 |
| 2025-11-05 | -1.57 |
| 2025-11-03 | -1.05 |
| 2025-10-31 | -1.57 |
| 2025-10-30 | -1.05 |
| 2025-10-28 | -1.57 |
| 2025-10-27 | -1.05 |
| 2025-10-24 | -1.57 |
| 2025-10-23 | -1.05 |
| 2025-10-22 | -1.57 |
| 2025-10-21 | -1.57 |
| 2025-10-20 | -1.57 |
| 2025-10-17 | -1.57 |
| 2025-10-16 | -1.57 |
| 2025-10-15 | -2.09 |